Su et al. used the lysosomal targeting properties of LAMP1 to construct a CryJ-LAMP vaccine, which can induce mice to produce high levels of IFN-γ and has the potential to treat allergies induced by Japanese bacteria by improving the Th1/Th2 status of the body [26]. Here, LAMP1 is linked to allergic disease.